Moderna stock at EUR 201.43 with USD 88.2 billion market value

Published on 10/12/2026 at 16:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Average target rose to USD 118.42 from USD 116.84. Moderna stock is at EUR 201.43 on October 12, 2026, with USD 88.2 billion value.

Key points in brief

Moderna stock was at EUR 201.43 at Lang & Schwarz on October 12, 2026 at 4:46 p.m. CEST.
The Nasdaq quote was USD 222.32, within a USD 22.28 to USD 227.38 52-week range.
Moderna had a USD 88.2 billion market capitalization and a minus 27.86 P/E ratio.
The next scheduled investor webcast is October 24, 2026, while the average analyst target is USD 118.42.

Isometrische 3D-Grafik zeigt Pharma-Wertschöpfungskette von Labor bis Krankenhaus — Moderna Inc. (US60770K1034) illustriert die isometrische Wertschöpfungskette der Biotech-Branche von Forschung bis zur finalen Auslieferung, Illustration mit AI erstellt.

Moderna stock (ISIN US60770K1079) was trading at EUR 201.43 at Lang & Schwarz on October 12, 2026 at 4:46 p.m. CEST. Moderna had a USD 88.2 billion market capitalization, while its Nasdaq quote was USD 222.32 at 10:57 a.m. ET. StockAnalysis identifies Moderna as a biotechnology company listed on NASDAQ under ticker MRNA.

Range leaves little room below the high

The Nasdaq price of USD 222.32 on October 12, 2026 stood within the 52-week range of USD 22.28 to USD 227.38. That places the quote USD 5.06 below the 52-week high, equal to 2.22 percent below the high.

Trading volume reached 4,999,198 shares by 10:57 a.m. ET, compared with an average volume of 18,261,732 shares. The gap between current and average turnover gives the session a measurable liquidity reference without changing the euro price used for this report.

Valuation and analyst target

Moderna's trailing P/E ratio was minus 27.86 on October 12, 2026, while its market capitalization stood at USD 88.2 billion. The company reported 4,700 employees in the latest company profile, which also lists healthcare as the sector and biotechnology as the industry.

TradingView reported that the average 12-month analyst target rose from USD 116.84 to USD 118.42, based on estimates from 19 analysts. The consensus rating remained Hold across 27 analysts, including 6 Buy ratings, 16 Hold ratings and 5 Sell ratings.

Comparison with peers

Moderna Inc.: , P/E minus 27.86, market capitalization USD 88.2 billion

Pfizer (NYSE, USD): plus 0.27 percent, P/E 37.45, market capitalization USD 161.6 billion

BioNTech (NASDAQ, USD): minus 0.58 percent, P/E minus 12.78, market capitalization USD 24.2 billion

The next dated investor event

Moderna scheduled an investor webcast for October 24, 2026 at 7:00 p.m. CEST, according to its September 30, 2026 press-release listing. The event date gives the market a defined calendar point alongside the current valuation figures.

At Lang & Schwarz, Moderna stock was trading at EUR 201.43 on October 12, 2026 at 4:46 p.m. CEST. The continuously updated real-time quote of Moderna stock.